Purinergic control of lysenin’s transport and voltage-gating properties

[1]  G. Burnstock An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration , 2016, Neuropharmacology.

[2]  G. Burnstock Blood cells: an historical account of the roles of purinergic signalling , 2015, Purinergic Signalling.

[3]  Jie Zheng,et al.  Proton block of proton-activated TRPV1 current , 2015, The Journal of general physiology.

[4]  G. Burnstock,et al.  P2X7 receptors and Fyn kinase mediate ATP-induced oligodendrocyte progenitor cell migration , 2015, Purinergic Signalling.

[5]  M. Miras-Portugal,et al.  The vesicular nucleotide transporter (VNUT) is involved in the extracellular ATP effect on neuronal differentiation , 2015, Purinergic Signalling.

[6]  V. Ralevic,et al.  Raised tone reveals ATP as a sympathetic neurotransmitter in the porcine mesenteric arterial bed , 2014, Purinergic Signalling.

[7]  Carole Gauron,et al.  Adenosine enhances progenitor cell recruitment and nerve growth via its A2B receptor during adult fin regeneration , 2014, Purinergic Signalling.

[8]  Cynthia Chatterjee,et al.  P2X receptors regulate adenosine diphosphate release from hepatic cells , 2014, Purinergic Signalling.

[9]  R. Nicholas,et al.  UTP is not a biased agonist at human P2Y11 receptors , 2014, Purinergic Signalling.

[10]  P. Rorsman,et al.  ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion , 2014, Diabetologia.

[11]  D. Otzen,et al.  Bacterial RTX Toxins Allow Acute ATP Release from Human Erythrocytes Directly through the Toxin Pore* , 2014, The Journal of Biological Chemistry.

[12]  L. Dušek,et al.  Lack of adenosine A3 receptors causes defects in mouse peripheral blood parameters , 2014, Purinergic Signalling.

[13]  M. Tsukimoto,et al.  Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells , 2014, Purinergic Signalling.

[14]  R. North,et al.  Ectodomain Movements of an ATP-gated Ion Channel (P2X2 Receptor) Probed by Disulfide Locking* , 2014, The Journal of Biological Chemistry.

[15]  I. Novak,et al.  Role of vesicular nucleotide transporter VNUT (SLC17A9) in release of ATP from AR42J cells and mouse pancreatic acinar cells , 2014, Purinergic Signalling.

[16]  G. Salamo,et al.  A model for the hysteresis observed in gating of lysenin channels. , 2013, Biophysical chemistry.

[17]  Damien Lemoine,et al.  Exploring the ATP-binding site of P2X receptors , 2013, Front. Cell. Neurosci..

[18]  E. Adinolfi New intriguing roles of ATP and its receptors in promoting tumor metastasis , 2013, Purinergic Signalling.

[19]  R. Benz,et al.  Differences in Purinergic Amplification of Osmotic Cell Lysis by the Pore-Forming RTX Toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the Role of Pore Size , 2013, Infection and Immunity.

[20]  D. Fologea,et al.  Cationic Polymers Inhibit the Conductance of Lysenin Channels , 2013, TheScientificWorldJournal.

[21]  Ann Chi Yan Wong,et al.  ATP-gated ion channels mediate adaptation to elevated sound levels , 2013, Proceedings of the National Academy of Sciences.

[22]  R. McCrimmon,et al.  AMPK modulates glucose-sensing in insulin-secreting cells by altered phosphotransfer to KATP channels , 2013, Journal of Bioenergetics and Biomembranes.

[23]  E. Volpi,et al.  Structures of Lysenin Reveal a Shared Evolutionary Origin for Pore-Forming Proteins And Its Mode of Sphingomyelin Recognition , 2012, Structure.

[24]  M. Hattori,et al.  Molecular mechanism of ATP binding and ion channel activation in P2X receptors , 2012, Nature.

[25]  G. Burnstock Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  Geoffrey Burnstock,et al.  Purinergic signalling , 2012, Acta physiologica.

[27]  G. Salamo,et al.  Bi-stability, hysteresis, and memory of voltage-gated lysenin channels. , 2011, Biochimica et biophysica acta.

[28]  Tobias Wang,et al.  Python Erythrocytes Are Resistant to α-Hemolysin from Escherichia coli , 2011, The Journal of Membrane Biology.

[29]  H. Praetorius,et al.  Haemolysis induced by α-toxin from Staphylococcus aureus requires P2X receptor activation , 2011, Pflügers Archiv - European Journal of Physiology.

[30]  G. Salamo,et al.  Potential analytical applications of lysenin channels for detection of multivalent ions , 2011, Analytical and bioanalytical chemistry.

[31]  G. Salamo,et al.  Multivalent ions control the transport through lysenin channels. , 2010, Biophysical chemistry.

[32]  Xiao Tao,et al.  A Gating Charge Transfer Center in Voltage Sensors , 2010, Science.

[33]  U. Jensen,et al.  Escherichia coli α-Hemolysin Triggers Shrinkage of Erythrocytes via KCa3.1 and TMEM16A Channels with Subsequent Phosphatidylserine Exposure* , 2010, The Journal of Biological Chemistry.

[34]  G. Burnstock,et al.  Evolutionary origins of the purinergic signalling system , 2009, Acta physiologica.

[35]  N. Jørgensen,et al.  α-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis , 2009, Proceedings of the National Academy of Sciences.

[36]  S. Licht,et al.  Use of calculated cation-pi binding energies to predict relative strengths of nicotinic acetylcholine receptor agonists. , 2008, ACS chemical biology.

[37]  G. Burnstock Purinergic signalling: past, present and future. , 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[38]  Toshihide Kobayashi,et al.  Lysenin: a sphingomyelin specific pore-forming toxin. , 2008, Biochimica et biophysica acta.

[39]  F. Goot,et al.  Bacterial pore-forming toxins: The (w)hole story? , 2008, Cellular and Molecular Life Sciences.

[40]  G. Burnstock,et al.  Purine and pyrimidine receptors , 2007, Cellular and Molecular Life Sciences.

[41]  F. G. van der Goot,et al.  Pore-forming toxins and cellular non-immune defenses (CNIDs). , 2007, Current opinion in microbiology.

[42]  A. Szewczyk,et al.  Lysenin-His, a sphingomyelin-recognizing toxin, requires tryptophan 20 for cation-selective channel assembly but not for membrane binding , 2007, Molecular membrane biology.

[43]  F. G. van der Goot,et al.  About lipids and toxins , 2006, FEBS letters.

[44]  T. Yanagida,et al.  Lysenin forms a voltage-dependent channel in artificial lipid bilayer membranes. , 2006, Biochemical and biophysical research communications.

[45]  G. Burnstock Pathophysiology and Therapeutic Potential of Purinergic Signaling , 2006, Pharmacological Reviews.

[46]  M. Parker,et al.  Pore-forming protein toxins: from structure to function. , 2005, Progress in biophysics and molecular biology.

[47]  Mark S.P. Sansom,et al.  Voltage-gated ion channels , 2005, Current Biology.

[48]  R. Sabirov,et al.  Wide nanoscopic pore of maxi-anion channel suits its function as an ATP-conductive pathway. , 2004, Biophysical journal.

[49]  R. Evans,et al.  Molecular properties of ATP-gated P2X receptor ion channels. , 2004, Trends in pharmacological sciences.

[50]  E. Schwiebert,et al.  Extracellular ATP as a signaling molecule for epithelial cells. , 2003, Biochimica et biophysica acta.

[51]  H. Kimura-Suda,et al.  Oligomerization and Pore Formation of a Sphingomyelin-specific Toxin, Lysenin* , 2003, Journal of Biological Chemistry.

[52]  A. Sobota,et al.  Lysenin, a unique sphingomyelin‐binding protein , 2003, FEBS letters.

[53]  R. Gilbert,et al.  Pore-forming toxins , 2002, Cellular and Molecular Life Sciences CMLS.

[54]  Richard J. Evans,et al.  The Role of Positively Charged Amino Acids in ATP Recognition by Human P2X1 Receptors* , 2000, The Journal of Biological Chemistry.

[55]  W. Stacey,et al.  Surface charge and lanthanum block of calcium current in bullfrog sympathetic neurons. , 1998, Biophysical journal.

[56]  G. Burnstock,et al.  Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gut , 1997, British journal of pharmacology.

[57]  T. Traut,et al.  Physiological concentrations of purines and pyrimidines , 1994, Molecular and Cellular Biochemistry.

[58]  P. Quinton,et al.  Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding , 1992, Nature.

[59]  G. Rousseau Purinergic Nerves , 1977, The Lancet.

[60]  K. Kirk,et al.  The CFTR ion channel: gating, regulation, and anion permeation. , 2013, Cold Spring Harbor perspectives in medicine.

[61]  Geoffrey Burnstock,et al.  Introductory overview of purinergic signalling. , 2011, Frontiers in bioscience.

[62]  G. Salamo,et al.  Controlled gating of lysenin pores. , 2010, Biophysical chemistry.

[63]  M. Leippe,et al.  Dissection of the mechanisms of cytolytic and antibacterial activity of lysenin, a defence protein of the annelid Eisenia fetida. , 2006, Developmental and comparative immunology.

[64]  C. Bashford Pore-forming toxins: attack and defence at the cell surface , 2001 .

[65]  R. Evans,et al.  The role of positively charged amino acids in ATP recognition by human P2X(1) receptors. , 2000, The Journal of biological chemistry.